Activators of the nuclear receptor PPARγ enhance colon polyp formation

[1]  J. Auwerx,et al.  Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice , 1998, Nature Medicine.

[2]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[3]  B. Spiegelman,et al.  Terminal differentiation of human breast cancer through PPAR gamma. , 1998, Molecular cell.

[4]  E. Giovannucci,et al.  The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. , 1997, The American journal of clinical nutrition.

[5]  A. Bull,et al.  Fatty acids and colon cancer in experimental models. , 1997, The American journal of clinical nutrition.

[6]  M. Taketo,et al.  Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc(delta716) knockout mice. , 1997, Carcinogenesis.

[7]  Bandaru S. Reddy,et al.  Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. , 1997, Cancer research.

[8]  J. Weisburger.  Dietary fat and risk of chronic disease: mechanistic insights from experimental studies. , 1997, Journal of the American Dietetic Association.

[9]  Barry M. Forman,et al.  Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .

[10]  Peter J. Brown,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .

[11]  W F Bodmer,et al.  Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  B. Spiegelman,et al.  Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[14]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[15]  M. D. Leibowitz,et al.  Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. , 1996, Endocrinology.

[16]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[17]  J. Lehmann,et al.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.

[18]  B. Spiegelman,et al.  15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.

[19]  T. Sugimura,et al.  Effects of docosahexaenoic acid (DHA) on intestinal polyp development in ApcΔ716 knockout mice , 1995 .

[20]  M. Kondo,et al.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.

[21]  A. Moser,et al.  ApcMin: a mouse model for intestinal and mammary tumorigenesis. , 1995, European journal of cancer.

[22]  S Jothy,et al.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.

[23]  J. Lehmann,et al.  An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.

[24]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.

[25]  Stephen A. Smith,et al.  [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents. , 1994, Journal of medicinal chemistry.

[26]  K. Umesono,et al.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Christine Dreyer,et al.  Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.

[28]  B. Reddy,et al.  Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. , 1991, Cancer research.

[29]  S. Sugie,et al.  Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. , 1988, Cancer research.

[30]  N. Temple,et al.  Effect of high fat and nutrient depleted diets on colon tumor formation in mice. , 1987, Cancer letters.

[31]  B. Reddy,et al.  Effect of different levels of dietary trans fat or corn oil on azoxymethane-induced colon carcinogenesis in F344 rats. , 1985, Journal of the National Cancer Institute.

[32]  A. Shamsuddin,et al.  Large intestinal carcinogenesis. I. Promotional effect of dietary fatty acid isomers in the rat model. , 1984, Journal of the National Cancer Institute.

[33]  B. Reddy,et al.  Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. , 1984, Journal of the National Cancer Institute.

[34]  M. Lazar,et al.  The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers. , 1998, Carcinogenesis.